Jan Smilek has been named chief financial officer at Akonni Biosystems.
He most recently was CFO and treasurer of Sucampo Pharmaceuticals. He was also senior director of finance for Vanda Pharmaceuticals and served as a senior manager for PricewaterhouseCoopers.
Smilek holds a BS in economics from the School of Economics in Bratislava, Slovakia, and an MBA from Georgetown University.
Exosome Diagnostics has named new members to its scientific advisory board, including John Quackenbush, Bob Carter, Carlos Cordon-Cardo, and Keith Flaherty.
Quackenbush is a professor at Dana-Faber Cancer Institute's Department of Computational Biology and Bioinformatics. Carter is chief of neurosurgery at the University of California, San Diego; Cordon-Cardo is vice chairman of pathology and a professor of pathology and urology at Columbia University; and Flaherty is director of developmental therapeutics at the Massachusetts General Hospital Cancer Center.